Answers are grounded in this paper and cite their sources.
Absence of the portal vein because of atrophy, agenesis, or aplasia can lead to both end-stage liver disease and hepatic tumors and therefore can be an indication for transplantation. We report the case of a successfully transplanted graft from a recipient with absence of the extrahepatic portal venous system. This situation has never been previously described in the literature. CASE REPORT This donor, deceased after brain death, was a 45-year-old woman who died from a subarachnoid hemorrhage. Her medical history included a splenectomy at the age of 10 years (reason not known), an aneurysm clipped at the age of 15 years, and a laparotomy at the age of 21 years for a traumatic perforated stomach and intestine after a road traffic accident. She also had undergone a caesarian section at the age of 32 years after which she was jaundiced and a cholecystectomy at the age of 42 years. Just before organ donation, her liver function tests were normal. The liver appearance was normal. However, during liver retrieval, it was noted that the extrahepatic portal vein was not present. A large-diameter common hepatic artery was identified. No difficulty was encountered in dissecting the porta because of collaterals. The pancreas was not retrieved. Back-table dissection of the liver confirmed normal anatomy except for the absence of the extrahepatic portal vein to the level of the hilar plate. Portal vein collaterals were found and could be traced to a bifurcation into the left and right intrahepatic portal venous systems. Donor iliac vein was anastomosed to the intrahepatic portal vein bifurcation on the back table, and an angiogram was performed on the bench (Fig. 1a).FIGURE 1.: (a) Angiogram showing donor iliac vein anastamosed to intrahepatic portal vein bifurcation. (b) Postoperative computed tomography scan with vascular reconstruction iliac conduit proximal anastamosis (red arrow) and distal anastamosis to recipient (yellow arrow).The recipient was a 68-year-old woman with primary biliary cirrhosis. Model for end-stage liver disease score was18. The portal vein was patent. The donor portal venous anomaly and the absence of guiding medical literature were explained to the patient. After this, the patient elected to undergo transplantation. The allograft was implanted using a side-to-side cavocavostomy with temporary portocaval shunt. Initial reperfusion followed arterial reconstruction. Reperfusion was tolerated, and liver appearance was satisfactory. The reconstituted donor vein was anastomosed in an end-to-end fashion to the patent recipient portal vein. A duct-to-duct biliary anastomosis was performed. A postoperative computed tomography scan with vascular reconstruction demonstrates the transplanted hepatic vascular anatomy (Fig. 1b). Her alanine aminotransferase peaked at 1082 on day 2 and decreased to 155 by day 10. However, alanine aminotransferase began to increase leading to a liver biopsy on day 13. This demonstrated acute cellular rejection, treated with methylprednisolone. The recipient has now been followed up for 4 years, and computed tomography scan confirms patency of the portal vein. Recurrent PBC has been confirmed by liver biopsy although she remains well with good liver function. DISCUSSION There are no previous reports of a liver with portal vein atrophy being transplanted. A possible explanation for the absence of an extrahepatic portal system seen in this donor is previous portal vein thrombosis. This is the likely explanation given her medical history. Alternatively, it could be due to a true congenital abnormality. This is a rare condition in which the enteric blood bypasses the liver and drains directly into the systemic circulation. It can be subdivided into type 1 with no portal vein perfusion to the liver and type 2 where there remains a degree of portal perfusion (1–3). It has a female preponderance and is generally diagnosed in adolescence. The absence of portal vein is often associated with liver abnormalities and can cause an increase in transaminases, portosytemic encephalopathy, and growth retardation in the young (2–5). Liver transplantation is indicated when there is portosystemic encephalopathy refractory to medical treatment or development of a tumor (3, 6). After back table dissection of the porta hepatis after retrieval, portal vein collaterals could be found. These converged onto a hypoplastic left and right portal vein, which allowed portal vein reconstruction. There was compensatory hypertrophy of the hepatic artery, as a consequence of the portal venous hypoplasia. With a number of patients with congenital portosystemic anomalies ultimately requiring transplantation, the use of a liver with absence of the extrahepatic portal vein for transplantation required careful consideration. If supply of donor organs were unlimited, then such an organ would never have been considered for transplantation. To maximize the donor pool and benefit the cohort of potential recipients, suboptimal grafts should be matched to recipients. Clearly, the use of an organ such as the liver described above in a young recipient with severe liver failure and a high model for end-stage liver disease may well have a limited lifespan. Therefore, the donor was chosen based on her age and stable liver disease, plus the absence of encephalopathy, so that an informed decision could be made about transplantation of an extended criteria allograft. Anya Adair Mark E. Brooke-Smith Murat Akyol James J.
No takes yet. Share an insight, caveat, or question.
Adair et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: